netrin-1 targeting humanized mAbs (New York University/MRCT)

N/A

Report date: 2025/03/20 14:57:19

Base Information

Drug Namenetrin-1 targeting humanized mAbs (New York University/MRCT)
Drug Alias Namenetrin-1 inhibitors (New York University)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionNetrin 1 blockersMacrophage migration inhibitory factor modulators
TargetsMacrophage migration inhibitory factorNetrin 1
Therapy Area/IndicationsAtherosclerosisVascular DiseasesCoronary Artery Disease +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNew York University
China Registration ClassN/A

Develop Information

Active CompaniesLifearc
Inactive CompaniesNew York University
Active IndicationsVascular DiseasesCoronary Artery DiseaseArthritis +[6] 
Inactive IndicationsAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A